Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in developed countries and it is now considered a risk factor for cardiovascular disease …

Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for advanced liver
disease, type 2 diabetes (T2DM), and cardiovascular diseases. The prevalence of NAFLD in …

Several liver disorders result from perturbations in the metabolism of hepatocytes, and their
underlying mechanisms can be outlined through the use of genome-scale metabolic models …

OBJECTIVE The 2019 Standards of Medical Care in Diabetes suggested that patients with
nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. However, the …

Ectopic fat accumulation in the liver causes nonalcoholic fatty liver disease (NAFLD), which
is the most common cause of chronic liver disease in Western countries. Ectopic liver lipid …

Intrahepatic fat deposition has been demonstrated in patients with nonalcoholic fatty liver
disease (NAFLD). Genetic and environmental factors are important for the development of …

There are no licensed drugs for nonalcoholic fatty liver disease (NAFLD), and there is a lack
of consensus on the best outcome measures for controlled trials. This systematic review …

Nonalcoholic fatty liver disease (NAFLD) may be a cause of hepatocellular carcinoma
(HCC), but its high prevalence challenges current surveillance strategies. We aimed to …

Nonalcoholic fatty liver disease (NAFLD) is one of the major causes of chronic liver injury.
NAFLD includes a wide range of clinical conditions from simple steatosis to nonalcoholic …

Increased consumption of high-caloric carbohydrates contributes substantially to endemic
non-alcoholic fatty liver disease in humans, covering a histological spectrum from fatty liver …